103 related articles for article (PubMed ID: 38734239)
1. RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database.
Prieto PA; Goldberg MS; Martin B
J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38734239
[No Abstract] [Full Text] [Related]
2. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
Maddineni S; Dizon MP; Muralidharan V; Young LA; Sunwoo JB; Baik FM; Swetter SM
Ann Surg Oncol; 2024 Apr; 31(4):2737-2746. PubMed ID: 38216800
[TBL] [Abstract][Full Text] [Related]
3. Response to Prieto et al, "RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database".
Freeman SC; Paz Munoz E; Latour E; Lim JY; Yu W
J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38740332
[No Abstract] [Full Text] [Related]
4. Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
Hosein S; Drebin HM; Kurtansky NR; Olofsson Bagge R; Coit DG; Bartlett EK; Marchetti MA
J Surg Oncol; 2023 Jun; 127(7):1167-1173. PubMed ID: 36905337
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms.
Drebin HM; Hosein S; Kurtansky NR; Nadelmann E; Moy AP; Ariyan CE; Bello DM; Brady MS; Coit DG; Marchetti MA; Bartlett EK
J Am Coll Surg; 2024 Jan; 238(1):23-31. PubMed ID: 37870230
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract][Full Text] [Related]
7. External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes.
Li AT; Law J; Ch'ng S; Scolyer RA; Thompson JF; Lo SN; Varey AHR
Eur J Cancer; 2023 Aug; 189():112901. PubMed ID: 37263897
[TBL] [Abstract][Full Text] [Related]
8. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
Lo SN; Ma J; Scolyer RA; Haydu LE; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Ch'ng S; Mann GJ; Gershenwald JE; Thompson JF; Varey AHR
J Clin Oncol; 2020 Aug; 38(24):2719-2727. PubMed ID: 32530761
[TBL] [Abstract][Full Text] [Related]
9. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
El Sharouni MA; Varey AHR; Witkamp AJ; Ahmed T; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; Lo SN; van Gils CH
Br J Dermatol; 2021 Aug; 185(2):412-418. PubMed ID: 33657653
[TBL] [Abstract][Full Text] [Related]
10. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
[TBL] [Abstract][Full Text] [Related]
11. External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.
Freeman SC; Paz Munoz E; Latour E; Lim JY; Yu W
J Am Acad Dermatol; 2023 Nov; 89(5):967-973. PubMed ID: 37454700
[TBL] [Abstract][Full Text] [Related]
12. A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development.
Wang NN; Yang ZJ; Wang X; Chen LX; Zhao HM; Cao WF; Zhang B
Breast Cancer; 2018 Nov; 25(6):629-638. PubMed ID: 29696563
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
Rossi CR; Mocellin S; Campana LG; Borgognoni L; Sestini S; Giudice G; Caracò C; Cordova A; Solari N; Piazzalunga D; Carcoforo P; Quaglino P; Caliendo V; Ribero S;
Ann Surg Oncol; 2018 Jan; 25(1):271-279. PubMed ID: 29067603
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using Nomograms.
Gruber I; Henzel M; Schönfisch B; Stäbler A; Taran FA; Hahn M; Röhm C; Helms G; Oberlechner E; Wiesinger B; Nikolaou K; LA Fougère C; Wallwiener D; Hartkopf A; Krawczyk N; Fehm T; Brucker S
Anticancer Res; 2018 Jul; 38(7):4047-4056. PubMed ID: 29970530
[TBL] [Abstract][Full Text] [Related]
16. A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes.
Yang L; Zhao X; Yang L; Chang Y; Cao C; Li X; Wang Q; Song Z
Sci Rep; 2024 Apr; 14(1):9596. PubMed ID: 38671007
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
Shimazu K; Sato N; Ogiya A; Sota Y; Yotsumoto D; Ishikawa T; Nakamura S; Kinoshita T; Tsuda H; Ohi Y; Akiyama F; Noguchi S
Ann Surg Oncol; 2018 Sep; 25(9):2603-2611. PubMed ID: 29978372
[TBL] [Abstract][Full Text] [Related]
18. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
[TBL] [Abstract][Full Text] [Related]
19. Predicting non-sentinel lymph node metastasis in Australian breast cancer patients: are the nomograms still useful in the post-Z0011 era?
Tapia G; Ying V; Di Re A; Stellin A; Cai TY; Warrier S
ANZ J Surg; 2019 Jun; 89(6):712-717. PubMed ID: 31066184
[TBL] [Abstract][Full Text] [Related]
20. Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.
Olofsson Bagge R; Mikiver R; Marchetti MA; Lo SN; van Akkooi ACJ; Coit DG; Ingvar C; Isaksson K; Scolyer RA; Thompson JF; Varey AHR; Wong SL; Lyth J; Bartlett EK
JAMA Surg; 2024 Mar; 159(3):260-268. PubMed ID: 38198163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
